A tiny group of people with rectal cancer just experienced something of a scientific miracle: their cancer simply vanished after an experimental treatment. In a very small trial done by doctors at New York's Memorial Sloan Kettering...

NEW YORK – Artificial intelligence company Nucleai and Jefferson Health on Tuesday announced a collaboration to discover histological biomarkers that predict response to immunotherapy. Tel Aviv-based Nucleai will use its ATOM platform to...